<DOC>
	<DOC>NCT03007615</DOC>
	<brief_summary>To evaluate the safety of an investigational product through the verification of signs of irritability and sensitization of the genital mucosa, as well as the instrumental moisturizing efficacy by TEWL and barrier integrity analysis, in addition to the efficacy perceived by the volunteers.</brief_summary>
	<brief_title>Dermal and Gynecological Acceptability (Irritability and Sensitization in the Genital Mucosa) of an Investigational Product and Evaluation of Moisture Efficacy by TEWL and Perceived Efficacy.</brief_title>
	<detailed_description />
	<criteria>Healthy female sex with active sex life; Age group: between 45 and 65 years old; Menopause for at least six months; Whole skin in the region of product analysis; No history of reaction to products of the same category Understanding, agreement and signature of the Term of Free and Informed Consent. Gestation or risk of gestation; Use of antiinflammatory / immunosuppressive drugs (in the last 30 days and during the study); Active cutaneous pathologies (local and / or disseminated) in the evaluation area; Pathologies that cause suppression of immunity, such as diabetes, HIV, etc.; Endocrine pathologies such as thyroid disorders, ovarian or adrenal gland disorders; Any infection in the region of analysis of the product diagnosed at the time of inclusion; Other conditions considered by the investigating physician as reasonable for disqualification of the individual from the study participation.</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>